Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19. Zelek WM, Cole J, Ponsford MJ, Harrison RA, et al. Am J Respir Crit Care Med 2020 Sep 8. doi: 10.1164/rccm.202007-2778.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zelek WM, Cole J, Ponsford MJ, Harrison RA, et al. Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19. Am J Respir Crit Care Med 2020 Sep 8. doi: 10.1164/rccm.202007-2778.
PMID: 32897730